Bio-Path Holdings (BPTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,173 | 1,052 | 10,384 | 23,774 | 13,755 |
| Other current assets | 1,529 | 1,358 | 1,644 | 1,843 | 928 |
| TOTAL | $3,776 | $3,042 | $15,615 | $26,140 | $15,956 |
| Non-Current Assets | |||||
| PPE Net | 23 | 76 | 158 | 225 | 231 |
| Other Non-Current Assets | 84 | 102 | 198 | 203 | 288 |
| TOTAL | $107 | $178 | $356 | $428 | $519 |
| Total Assets | $3,883 | $3,220 | $15,971 | $26,568 | $16,475 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,274 | 457 | 667 | 106 | 100 |
| Accrued Expenses | 1,938 | 1,346 | 909 | 770 | 975 |
| TOTAL | $3,295 | $1,906 | $1,684 | $958 | $1,169 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 434 | 873 | 113 | 153 | 236 |
| TOTAL | $434 | $873 | $113 | $153 | $236 |
| Total Liabilities | $3,729 | $2,779 | $1,797 | $1,111 | $1,405 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8,308 | 679 | 398 | 358 | 347 |
| Common Shares | 6 | 1 | 1 | 7 | 5 |
| Retained earnings | -117,501 | -107,607 | -91,529 | -77,661 | -67,221 |
| TOTAL | $154 | $441 | $14,174 | $25,457 | $15,070 |
| Total Liabilities And Equity | $3,883 | $3,220 | $15,971 | $26,568 | $16,475 |